Kathy Warden J.'s Insider Trades & SAST Disclosures
Kathy Warden J.'s most recent trade in Northrop Grumman Corp. was a trade of 3,750 Common Stock done at an average price of $475.7 . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kathy Warden J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 475.65 per share. | 06 Mar 2025 | 3,750 | 212,852 (0%) | 0% | 475.7 | 1,783,688 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 27,417 | 100,629 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 27,350 | 222,190 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 27,350 | 73,279 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 441.36 per share. | 18 Feb 2025 | 12,335 | 209,855 (0%) | 0% | 441.4 | 5,444,176 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 11,752 | 45,339 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,672 | 33,667 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 11,672 | 221,527 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 441.36 per share. | 18 Feb 2025 | 4,925 | 216,602 (0%) | 0% | 441.4 | 2,173,698 | Common Stock |
| Merck & Co Inc | Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 12,252 | - | - | Phantom Stock | |
| Northrop Grumman Corp. | Warden Kathy J. | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 14,776 | 201,504 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Warden J. Kathy | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 14,776 | 33,587 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Warden J. Kathy | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 450.96 per share. | 16 Feb 2024 | 6,664 | 194,840 (0%) | 0% | 451.0 | 3,005,197 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 45,832 | 73,212 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Warden Kathy J. | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 45,832 | 207,063 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 37,636 | 119,044 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Warden J. Kathy | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.37 per share. | 14 Feb 2024 | 20,335 | 186,728 (0%) | 0% | 446.4 | 9,076,934 | Common Stock |
| Northrop Grumman Corp. | Kathy Warden J. | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 11,155 | 48,363 | - | - | Restricted Stock Rights | |
| Merck & Co Inc | Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 10,228 | - | - | Phantom Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 36,499 | 81,408 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 36,499 | 177,693 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,804 | 117,907 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 465.35 per share. | 16 Feb 2023 | 16,462 | 161,231 (0%) | 0% | 465.4 | 7,660,592 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 10,760 | 37,208 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 11,453 | 26,448 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 11,453 | 146,036 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 464.28 per share. | 13 Feb 2023 | 4,843 | 141,193 (0%) | 0% | 464.3 | 2,248,508 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 482.66 per share. | 04 Aug 2022 | 2,200 | 138,177 (0%) | 0% | 482.7 | 1,061,852 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 483.45 per share. | 04 Aug 2022 | 2,193 | 135,984 (0%) | 0% | 483.5 | 1,060,206 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 477.78 per share. | 04 Aug 2022 | 1,174 | 143,409 (0%) | 0% | 477.8 | 560,914 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 481.60 per share. | 04 Aug 2022 | 1,032 | 140,377 (0%) | 0% | 481.6 | 497,011 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 484.33 per share. | 04 Aug 2022 | 1,001 | 134,983 (0%) | 0% | 484.3 | 484,814 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 480.76 per share. | 04 Aug 2022 | 1,000 | 141,409 (0%) | 0% | 480.8 | 480,760 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 478.74 per share. | 04 Aug 2022 | 800 | 142,609 (0%) | 0% | 478.7 | 382,992 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 485.73 per share. | 04 Aug 2022 | 400 | 134,583 (0%) | 0% | 485.7 | 194,292 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Sale of securities on an exchange or to another person at price $ 479.51 per share. | 04 Aug 2022 | 200 | 142,409 (0%) | 0% | 479.5 | 95,902 | Common Stock |
| Merck & Co Inc | Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 8,018 | - | - | Phantom Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chair, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 09 May 2022 | 1,935 | 144,583 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 40,958 | 85,103 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 40,958 | 164,990 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 32,947 | 126,061 | - | - | Restricted Performance Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 384.77 per share. | 15 Feb 2022 | 18,472 | 146,518 (0%) | 0% | 384.8 | 7,107,471 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 11,672 | 37,901 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 14,227 | 130,065 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 14,227 | 26,229 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 390.60 per share. | 14 Feb 2022 | 6,033 | 124,032 (0%) | 0% | 390.6 | 2,356,490 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2021 | 4,943 | 40,456 | - | - | Restricted Stock Rights | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2021 | 4,943 | 118,068 (0%) | 0% | 0 | Common Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 348.81 per share. | 20 Sep 2021 | 2,230 | 115,838 (0%) | 0% | 348.8 | 777,846 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Aug 2021 | 915 | 113,125 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 2,635 | 5,310 | - | - | Phantom Stock | |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 352.04 per share. | 03 May 2021 | 4,916 | 114,040 (0%) | 0% | 352.0 | 1,730,629 | Common Stock |
| Northrop Grumman Corp. | Kathy J. Warden | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 33,653 | 117,222 | - | - | Restricted Performance Stock Rights | |
| Merck & Co Inc | Kathy J. Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 2,477 | 2,591 | - | - | Phantom Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges